From: Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
HCT-8 cell line
% cell growth inhibition
Beta-catenin expression
Control
0%
++++/strong
MSeA (1 μM)
~50%
++/weak
SN-38(0.7 μM)
~20%
MSeA+SN-38
>95%
+/very weak
ShRNA
ShRNA+SN38
~70%